FDA Inspection 1228326 — Nuvasive PR, Inc.
The FDA completed an inspection of Nuvasive PR, Inc. on January 18, 2024 in Guaynabo, PR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 18, 2024
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Guaynabo, PR (United States)